Carnosine Alleviates Knee Osteoarthritis And Promotes Synoviocyte Protection Via Activating The Nrf2 HO 1 Signaling Pathway An In Vivo And In Vitro Study

This study investigated whether carnosine, a naturally occurring compound found in muscle and brain tissue, could help treat knee osteoarthritis. Osteoarthritis is the most common joint disease in older adults, characterized by cartilage breakdown, bone changes, and reduced joint space that leads to pain and stiffness. The researchers wanted to understand if carnosine supplementation could protect joints and reduce inflammation.

The scientists conducted experiments using rats with surgically induced knee osteoarthritis, as well as laboratory studies on synovial cells (cells that line the joints). They measured pain levels, analyzed inflammatory proteins in blood and joint fluid, and examined joint tissue under microscopes. The rats receiving carnosine treatment showed significantly reduced pain and better joint protection compared to untreated animals.

The key finding was that carnosine worked by activating a specific cellular pathway called Nrf2/HO-1, which helps protect cells from damage and reduces inflammation. This activation led to decreased levels of inflammatory proteins like COX-2, while preserving the synovial tissue that cushions joints. The microscopic analysis revealed that carnosine treatment resulted in less cartilage degradation and better overall joint structure preservation.

For individuals interested in metabolic health and longevity, this research suggests that carnosine might offer joint protection benefits as we age. However, this was an animal study, so human clinical trials would be needed to confirm these effects in people. Patients interested in joint health should discuss evidence-based approaches with their healthcare providers rather than self-treating based on preliminary research.